The Court of Arbitration for Sport (CAS) has published the reasons for its decision in the doping case of 17-year-old Russian figure skater Kamila Valieva, who was disqualified for four years for doping. The 129-page document ( .pdf ) is posted on the CAS website.
The court's press release said that CAS found Valieva's version that she received the drug trimetazidine with her grandfather's dessert untenable. Valieva stated in court that the prohibited substance entered the body through a dessert prepared by her grandfather on a board where he crushed tablets containing trimetazidine.
CAS decided to disqualify Valieva as an adult athlete because the skater could not prove that she did not intentionally violate anti-doping rules, the press release said.
The court decision states that in addition to trimetazidine, hypoxene and L-carnitine, ecdysterone was found in Valieva’s body. Valieva could not explain how she received the drug that improves anabolism. Also, the sports doctors who worked with her could not explain this.
Ecdysterone is approved by the World Anti-Doping Agency (WADA), but is in the organization’s monitoring program in case of a possible ban, notes R-Sport. that a drug that improves anabolism was found in Valieva’s doping test in January The Finnish Yle was the first to report .
Ecdysterone, hypoxene, L-carnitine, as well as trimetazidine are “typical pharmacological support provided to athletes in Russia to aid in heavy training and improve recovery,” WADA witnesses Dr. York Schumacher of the University of Freiburg and Estonian sports physician Sergei told the court. Ilyukov, who until February 26, 2022 was a member of the supervisory board of the Russian Anti-Doping Agency (RUSADA).